Kaijie Peptide Co., Ltd.
⚠️ Moderate Risk
FEI: 3008577211 • Chengdu, Sichuan • CHINA
FEI Number
3008577211
Location
Chengdu, Sichuan
Country
CHINAAddress
Industrial Concentration, 137 Nanpu East Rd; Dev. Zone, Chengdu, Sichuan, China
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
LACKS FIRM
The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.
LACKS N/C
The article is in package form and appears to not have a label containing an accurate statement of the quantity of the contents in terms of weight, measure or numerical count and no variations or exemptions have been prescribed by regs.
DRUG NAME
The article appears to be a drug and fails to bear the proprietary or established name and/or name and quantity of each active ingredient.
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 12/11/2018 | 61UCT06HISTRELIN ACETATE (ANTI-ESTROGEN) | Division of Northern Border Imports (DNBI) | |
| 3/29/2017 | 56FIY99PEPTIDE N.E.C. | New Orleans District Office (NOL-DO) | |
| 3/29/2017 | 63XCZ83MANNITOL (DIAGNOSTIC AID) (DRUGS) | New Orleans District Office (NOL-DO) |
Frequently Asked Questions
What is Kaijie Peptide Co., Ltd.'s FDA import refusal history?
Kaijie Peptide Co., Ltd. (FEI: 3008577211) has 3 FDA import refusal record(s) in our database, spanning from 3/29/2017 to 12/11/2018.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Kaijie Peptide Co., Ltd.'s FEI number is 3008577211.
What types of violations has Kaijie Peptide Co., Ltd. received?
Kaijie Peptide Co., Ltd. has been cited for 7 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Kaijie Peptide Co., Ltd. come from?
All FDA import refusal data for Kaijie Peptide Co., Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.